|Articles|November 1, 2004
Risk awareness more important than ever for isotretinoin
New York - Discussing "What's Up with Isotretinoin" at the recent American Academy of Dermatology Academy '04 here, John S. Strauss, M.D., reported that much of the recent attention on oral retinoids continues to focus on the pregnancy risk management aspects of its use for the treatment of acne.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5














